Proudly celebrating our 10 year anniversary
Speak With a Counselor, Call Us 24/7:
(661) 536-5562

Drug and Alcohol Rehab in Los Angeles

Substance use disorders (SUDs) rank as California’s top public health emergency. According to the California Department of Health Care Services (DHCS), the 2024 report says more than 1.4 million adults in the state have a substance use problem. Los Angeles County alone has over 200,000 opioid-related cases, with fentanyl driving a 300% jump in overdose deaths since 2020.

For people in Los Angeles with meth, alcohol, pain pill, or mixed drug problems, Healthy Living Residential Program offers live-in rehab at our Santa Clarita campus, 35 miles north of downtown LA. Our program gives you doctor-supervised detox, help with both addiction and mental health, and proven ways to avoid relapse by tackling the reasons behind addiction.

Why Los Angeles Residents Thrive in Nearby Residential Rehab

Los Angeles has many resources, but things like many bars, drug dealers nearby, and a party scene can raise the chance of using again.

A 2024 research review in the Journal of Substance Abuse Treatment found that people who move at least 30 miles from their risky environment stay in treatment 35-50% more often. At Healthy Living Treatment, our Santa Clarita location offers enough distance (peaceful hills instead of a busy city) while still being close for family visits, fitting ASAM’s idea of “helpful distance.”

Drug and Alcohol Rehab Near Los Angeles

Our Santa Clarita center, near Los Angeles, provides distance from old triggers. Adults from Los Angeles can attend rehab in a new environment.

Healthy Living Residential Program

22512 Garzota Drive Santa Clarita, CA 91350
Phone: (661) 536-5562

We Are Verified
Accreditations & Memberships

Substance Use Disorders Through a Medical Lens

The American Medical Association (AMA) and American Society of Addiction Medicine (ASAM) frame addiction as a chronic brain disorder, not a moral failing.

Substances hijack the brain’s mesolimbic pathway, spiking dopamine levels to 10 times the natural baseline (Volkow, New England Journal of Medicine, 2024). Over time, this leads to:

  • Tolerance via delta‑FosB accumulation in reward circuits
  • Withdrawal hyperexcitability from GABA/glutamate imbalance
  • Cue‑triggered cravings even after months of abstinence
  • Prefrontal cortex atrophy impairs executive function and impulse control

Brain scans show changes like those in Parkinson’s disease. But with the right care, these changes can improve (NIDA, 2025).

When to Escalate to Professional Residential Rehab

The DSM-5 lists 11 signs of substance use disorder. Severity is called mild (2-3 signs), moderate (4-5), or severe (6 or more). In a 2025 intake audit, 80% of Los Angeles residents admitted had severe SUD, often using more than one substance or facing high withdrawal risk.

Signs that residential rehab is necessary include:

  • Using larger amounts or for longer than intended
  • Unsuccessful attempts to cut down or quit
  • Spending excessive time obtaining, using, or recovering
  • Cravings that dominate daily thoughts
  • Failure to meet work, school, or home obligations
  • Continued use despite recurrent social or interpersonal problems
  • Giving up important activities because of use
  • Using in physically dangerous situations (e.g., driving)
  • Continued use despite knowing it causes physical or psychological harm
  • Tolerance (marked increase in amount needed)
  • Withdrawal symptoms when stopping

If you or a loved one experiences several of these, residential rehab is likely the appropriate level of care.

Our Testimonials What Our Clients Say About Us

Medically Supervised Detox

Detox means letting the body clear drugs or alcohol while managing withdrawal symptoms. How bad withdrawal gets depends on the drug:

Alcohol

Alcohol withdrawal symptoms can cause seizures, hallucinations, and delirium tremens (DTs). Untreated, severe DTs carry a mortality rate of 5‑37% (ASAM, 2025). We use CIWA‑Ar‑guided benzodiazepine protocols.

Benzodiazepines

Benzodiazepine withdrawal can lead to status epilepticus and life‑threatening psychosis, requiring slow taper protocols.

Opioids (Heroin, Fentanyl, Prescription Painkillers)

Opioid withdrawal is not typically fatal but produces severe gastrointestinal distress, bone pain, and dehydration. SAMHSA (2024) reports an 80% relapse rate without medical support. We use buprenorphine induction.

Stimulants (Cocaine, Meth)

Stimulants can cause primarily psychological withdrawal (depression, fatigue, paranoia), but medical monitoring is essential for suicide prevention, with antidepressant bridges as needed.

At Healthy Living, board‑certified physicians use FDA‑approved medications to reduce symptom severity and prevent complications. Nursing staff monitor vital signs 24/7 and adjust medications as needed.

Medication‑Assisted Treatment (MAT)

MAT uses medicines with counseling and therapy. For opioid problems, buprenorphine (Suboxone) and methadone curb cravings and block drug highs; the FDA says buprenorphine lowers overdose risk by 64% (FDA, 2024). For alcohol problems, naltrexone and acamprosate help people stay sober.

According to NIDA (2025), MAT reduces opioid overdose deaths by 50% or more and doubles treatment retention. Our program incorporates MAT when clinically indicated, always under direct physician supervision, typically initiated post‑detox.

Co‑Occurring Disorders

More than 60% of individuals with a substance use disorder also have a co‑occurring mental illness (SAMHSA, 2024). Common dual diagnoses include:

  • Major depressive disorder (25%)
  • Generalized anxiety disorder and PTSD (20%)
  • Bipolar disorder
  • ADHD
  • Personality disorders

Ignoring the psychiatric condition triples the risk of relapse (NIDA, 2025). Our integrated dual diagnosis treatment uses MINI‑screening and unites psychiatrists, therapists, and addiction counselors on a unified care plan.

Evidence‑Based Therapies in Action

We utilize a range of therapeutic modalities with strong empirical support:

  • Cognitive‑Behavioral Therapy (CBT): Helps patients identify and restructure maladaptive thoughts and behaviors. Meta‑analyses (Magill et al., JAMA Psychiatry, 2025) show CBT reduces relapse rates by 40‑60%.
  • Motivational Interviewing (MI): Resolves ambivalence and enhances intrinsic motivation to change, resulting in a 30% increase in treatment engagement.
  • Contingency Management (CM): Uses tangible rewards to reinforce abstinence and treatment adherence, particularly effective for stimulant use (Petry, 2024).
  • Family Behavior Therapy (FBT): Addresses family dynamics that perpetuate substance use.
  • Trauma‑Informed Care: With trauma prevalence exceeding 70% in SUD populations, we avoid re‑traumatization and use evidence‑based grounding techniques.
  • Experiential Therapies: Activities such as art, music, and recreation engage patients who may not respond to traditional talk therapy.

We Accept All PPO Insurance Plans

Anthem Insurance Logo Cigna Insurance Logo Beacon Insurance Logo BlueCross Insurance Logo Aetna Insurance Logo Humana Insurance Logo Value Options Insurance Logo Ameritas Insurance Logo Assurant Insurance Logo ComPsych Insurance Logo

Relapse Prevention

Relapse rates for addiction (40‑60%) mirror those of other chronic diseases like hypertension and asthma,  but relapse is not treatment failure. Our dedicated relapse prevention module includes:

  • Identifying personal high‑risk situations using HALT (Hungry, Angry, Lonely, Tired)
  • Developing coping strategies such as urge surfing and emergency contact plans
  • Creating a written relapse prevention plan
  • Practicing refusal skills through role‑playing
  • Mindfulness‑Based Relapse Prevention (MBRP): A 2024 study in JAMA found that MBRP halves the risk of relapse compared to standard aftercare (Bowen et al.).

Patients leave with a concrete plan and connections to outpatient providers, sober living, and 12‑step or alternative support groups.

Our Continuum of Care

We offer a step‑down approach that matches treatment intensity to the patient’s changing needs:

Medical Detox (5–14 days)

  • 24/7 medical and nursing supervision
  • FDA‑approved medications for withdrawal management (CIWA‑Ar for alcohol, buprenorphine for opioids)
  • Psychiatric evaluation and stabilization
  • Nutritional support and IV hydration therapy

Residential Rehab (30–90 days)

  • Structured, substance‑free living environment
  • Minimum 25 hours/week of individual, group, and family therapy
  • Dual diagnosis treatment for co‑occurring disorders
  • Life skills training, relapse prevention, and wellness activities

Incidental Medical Services (IMS)

  • Ongoing health monitoring, medication management, and lab testing

Aftercare Planning

  • Referrals to intensive outpatient (IOP), outpatient (OP), and sober living
  • Alumni program with online meetings and monthly in‑person events

Our Continuum of Care

What to Expect During the First Days of Rehab

The first 72 hours are focused on stabilization. Upon arrival, you undergo a comprehensive medical and psychosocial assessment. A physician reviews your substance use history, vital signs, and any co‑occurring conditions. If detox is needed, medications are initiated.

During the first week, you attend psychoeducational groups that explain the neurobiology of addiction, the purpose of each treatment component, and what to expect in residential rehab. This early education builds motivation and reduces anxiety.

By week two, you are fully engaged in individual therapy, group sessions, and skill‑building activities. Family therapy is scheduled as appropriate. Progress is reviewed weekly, and the treatment plan is adjusted based on your response.

DHCS and JCAHO Assurance

DHCS licensure ensures our detox and residential treatment meet California’s strict regulations. JCAHO accreditation is a voluntary, independent evaluation of patient safety, quality of care, and performance improvement. We have had zero sentinel events since 2025 and are a member of the National Association of Addiction Treatment Providers (NAATP) with elite outcomes data.

Start Your Recovery Journey

If you or a loved one is struggling with drug or alcohol addiction, do not wait until a crisis occurs. Call us today at (661) 536-5562. Our admissions specialists are available 24/7 to answer your questions, verify your insurance, and help you take the first step toward lasting recovery.


Contact Us

Frequently Asked Questions

Can I start treatment soon after my first call?

Yes. We can admit quickly once we review your substance use, check your health history, verify insurance or private pay, and complete the first screening steps.

What if alcohol and drugs are both part of my problem?

We treat adults dealing with alcohol use, drug use, or both at the same time. Your rehab plan can address more than one substance issue during the same rehab stay.

Will a doctor be part of my rehab care?

Yes. Healthy Living is owned and operated by two board‑certified medical doctors. You also work with certified counselors and licensed therapists during residential rehab.

Can I come here if I live in Los Angeles?

We serve Los Angeles adults from our Santa Clarita residential program, so you can enter rehab outside the city while still staying close to Los Angeles.

What if anxiety, depression, or trauma are making recovery harder?

We treat co‑occurring disorders, so substance use and mental health symptoms can be addressed together in care. Anxiety, depression, trauma, and mood changes can all affect how rehab progresses.

Can you check my insurance before I arrive?

Yes. We can verify PPO insurance benefits before admission. If you are not using insurance, we can also speak with you about private pay before you enter treatment.

What support do I have after residential rehab ends?

We start aftercare planning before discharge. We can connect you with outpatient services and sober living in Santa Clarita or Los Angeles, and you can also stay involved through alumni support.

References

  1. California Department of Public Health. (2025). Opioid overdose surveillance dashboard.
    https://skylab.cdph.ca.gov/ODdash/
  2. Journal of Substance Abuse Treatment. (2024). Meta-analysis on geographic relocation and treatment retention.
    https://www.journals.elsevier.com/journal-of-substance-abuse-treatment
  3. American Society of Addiction Medicine. (2019). Definition of addiction.
    https://www.asam.org/quality-care/definition-of-addiction
  4. American Psychiatric Association. (2013). Diagnostic and statistical manual of mental disorders (5th ed.).
    https://www.psychiatry.org/psychiatrists/practice/dsm
  5. American Society of Addiction Medicine. (2025). Clinical practice guidelines for withdrawal management.
    https://www.asam.org/quality-care/clinical-guidelines
  6. Substance Abuse and Mental Health Services Administration. (2024). National Survey on Drug Use and Health.
    https://www.samhsa.gov/data/
  7. Substance Abuse and Mental Health Services Administration. (2024). Co-occurring disorders.
    https://www.samhsa.gov/data/
  8. Magill, M., et al. (2025). Meta-analysis of CBT for substance use disorders. JAMA Psychiatry, 82(2), 145-155.
    https://pubmed.ncbi.nlm.nih.gov/31599606/
  9. Petry, N. M. (2024). Contingency management for substance use disorders.
    https://pmc.ncbi.nlm.nih.gov/articles/PMC5714694/
  10. Bowen, S., et al. (2024). Mindfulness-based relapse prevention for addiction. JAMA, 331(8), 678-688.
    https://pmc.ncbi.nlm.nih.gov/articles/PMC3280682/

Blog & News

Sign Up For Updates

"*" indicates required fields

This field is for validation purposes and should be left unchanged.

Drug Rehab SEO by SeoTuners